Cerebras Systems told investors in its SEC registration statement that its chips were designed for reliable performance “in all workload scenarios.” The same document disclosed a one-to-two-year warranty, which overlaps a short seller’s alleged 1.5-to-2.5-year failure window.

NEW YORK, Oct. 29, 2026 /PRNewswire/ — Cerebras Systems (CBRS) shareholders lost roughly 5.7% of their investment’s value after Culper Research disclosed a short position and alleged that the Company’s wafer-scale AI processors could fail within approximately 1.5 to 2.5 years. That timeline overlaps the one-to-two-year warranty Cerebras disclosed in its SEC registration statement. If you lost money on CBRS shares, you may have legal rights and are encouraged to act now. Submit your CBRS loss details here or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

In the draft registration statement it submitted to the SEC on June 17, 2024, Cerebras stated that its packaging technique was “designed to enable reliable and high performance in all workload scenarios.” The same document stated the Company was “committed to rigorous quality control throughout the manufacturing process to confirm reliability in even the most demanding environments at our customer facilities.”

That registration statement also disclosed that Cerebras “generally warrants its products to be free of defects generally for a period of one to two years.” The Company accrued for estimated returns of defective products based on historical experience. Its warranty provision rose from approximately $538,000 in 2022 to approximately $3.633 million in 2023. The filing did not provide failure rates, expected processor life, or replacement obligations.

Culper’s claims remain allegations. Levi & Korsinsky is investigating whether Cerebras’s SEC disclosures may not have adequately addressed processor durability risks.

Investors who suffered losses on Cerebras Systems stock may request a free review of their CBRS losses or call (212) 363-7500.

WHY LEVI & KORSINSKY — Ranked in ISS Securities Class Action Services’ Top 50 Report for seven consecutive years, Levi & Korsinsky, LLP is a nationally recognized leader in shareholder rights litigation. With a team of over 70 professionals, the firm has recovered hundreds of millions of dollars for investors.

Frequently Asked Questions About the CBRS Investigation

Q: Who is eligible to participate in the CBRS investigation?A: Investors who purchased CBRS stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses — not on whether you still hold the shares.

Q: How much did CBRS stock drop?A: Shares fell approximately 5.7% after Culper Research disclosed a short position and published a report alleging that Cerebras’s wafer-scale AI processors could fail within approximately 1.5 to 2.5 years. Investors who purchased shares at allegedly inflated prices and suffered losses may be eligible to seek compensation.

Q: Which statements are being investigated as potentially misleading?A: The investigation concerns whether Cerebras Systems made materially false or misleading statements about the reliability and durability of its wafer-scale processors. This includes SEC registration statement language describing reliable performance “in all workload scenarios.” When Culper Research published its report alleging processor failures within approximately 1.5 to 2.5 years, the stock price declined.

Q: What do CBRS investors need to do right now?A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery. No immediate action is required to remain eligible to participate in the investigation.

Q: What documents do I need to participate?A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if I already sold my CBRS shares — can I still recover losses?A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought CBRS and sold at a loss may still participate in the investigation.

Q: What does it cost me to participate?A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys’ fees and expenses subject to court approval.

Q: What if I live outside the United States?A: U.S. securities investigations generally cover purchases on U.S. exchanges regardless of the investor’s country of residence.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

View original content to download multimedia:https://www.prnewswire.com/news-releases/cerebras-systems-investigation-notice-levi–korsinsky-notifies-investors-of-pending-investigation-into-cerebras-systems-cbrs-302924075.html

SOURCE Levi & Korsinsky, LLP